Detalhe da pesquisa
1.
Nivolumab plus Ipilimumab versus Sunitinib in Advanced Renal-Cell Carcinoma.
N Engl J Med
; 378(14): 1277-1290, 2018 Apr 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-29562145
2.
Nivolumab plus ipilimumab versus sunitinib in first-line treatment for advanced renal cell carcinoma: extended follow-up of efficacy and safety results from a randomised, controlled, phase 3 trial.
Lancet Oncol
; 20(10): 1370-1385, 2019 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-31427204
3.
Molecular Epidemiology of ALK Rearrangements in Advanced Lung Adenocarcinoma in Latin America.
Oncology
; 96(4): 207-216, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-30476928
4.
Avelumab versus docetaxel in patients with platinum-treated advanced non-small-cell lung cancer (JAVELIN Lung 200): an open-label, randomised, phase 3 study.
Lancet Oncol
; 19(11): 1468-1479, 2018 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-30262187
5.
Nivolumab versus Docetaxel in Advanced Squamous-Cell Non-Small-Cell Lung Cancer.
N Engl J Med
; 373(2): 123-35, 2015 Jul 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-26028407
6.
First-line nivolumab plus ipilimumab for metastatic non-small cell lung cancer, including patients with ECOG performance status 2 and other special populations: CheckMate 817.
J Immunother Cancer
; 11(2)2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36725084
7.
Avelumab Versus Docetaxel in Patients With Platinum-Treated Advanced NSCLC: 2-Year Follow-Up From the JAVELIN Lung 200 Phase 3 Trial.
J Thorac Oncol
; 16(8): 1369-1378, 2021 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-33845211
8.
Survival outcomes and independent response assessment with nivolumab plus ipilimumab versus sunitinib in patients with advanced renal cell carcinoma: 42-month follow-up of a randomized phase 3 clinical trial.
J Immunother Cancer
; 8(2)2020 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-32661118
9.
Cabozantinib, a New Standard of Care for Patients With Advanced Renal Cell Carcinoma and Bone Metastases? Subgroup Analysis of the METEOR Trial.
J Clin Oncol
; 36(8): 765-772, 2018 03 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-29309249
10.
Análisis de la patología neoplásica del PRONACAM-COMEF / Analysis of the neoplasic pathology of PRONACAM-COMEF
In. Uruguay. Ministerio de Salud Pública. Programa Nacional de Cáncer de Mama. Trabajos científicos presentados en las Segundas Jornadas del PRONACAM. Montevideo, Uruguay. Ministerio de Salud Pública, 1993. p.9-12, tab.
Monografia
em Espanhol
| LILACS | ID: lil-182041